Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 1, 1998, Pages 88-99

  Marian, Ali J ^a   Roberts, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genes; Genetics; Hypertrophic cardiomyopathy; Mutations; Sarcomere; Sudden cardiac death

Indexed keywords

ENVIRONMENTAL FACTOR; GENE MUTATION; HEART WORK; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; REVIEW; SARCOMERE; SUDDEN DEATH;

EID: 0031933491     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00871.x     Document Type: Review

References (83)

1. Marian AJ, Roberts R: Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-1347.
2. Schwartz K, Carrier L, Guicheney P, et al: Molecular basis of familial cardiomyopathies. Circulation 1995; 91:532-540.
3. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: A genetic model of cardiac hypertrophy. Human Mol Genet 1995;4:1721-1727.
4. Ferrans VJ, Morrow AG, Roberts WC: Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation 1972;45:769-792.
5. Maron BJ, Shirani J, Poliac LC, et al: Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276;199-204.
6. Maron BJ, Gardin JM, Flack JM, et al: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in Adults. Circulation 1995;92:785-789.
7. Savage DD, Castelli WP, Abbott RO, et al: Hypertrophic cardiomyopathy and its markers in the general population. The great masquerader revisited: The Framingham Study. J Cardiovasc Ultrasonogr 1983:2:41-47.
8. Spirito P, Chiarella F, Carratino L, et al: Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-755.
9. Kofflard MJ, Waldstein DJ, Vos J, et al: Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993;72:939-943.
10. Maron BJ, Spirito P: Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993;72:970-972.
11. McKenna W, Deanfield J, Farugui A, et al: Prognosis in hypertrophic cardiomyopathy: Role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538.
12. Thierfelder L, Watkins H, MacRae C, et al: α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994;77:701-712.
13. Geisterfer-Lawrance AA, Kass S, Tanigawa G, et al: A molecular basis for familial hypertrophic cardiomyopathy: A β-cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
14. Watkins H, Conner D, Thierfelder L, et al: Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genetics 1995;11:434-437
15. Bonne G, Carrier L, Bercovici J, et al: Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genetics 1995;11:438-440.
16. Poetter K, Jiang H, Hassanzadeh S, et al: Mutations in either the essential or regulatory light chains of myosin are associated with a rate myopathy in human heart and skeletal muscle. Nature Genet 1996;13:63-69.
17. Kimura A, Harada H, Park J-E, et al: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet 1997;16:379-382.
18. Jarcho JA, McKenna W, Pare JAP, et al: Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989;321:1372-1378.
19. Hejtmancik JF, Brink PA, Towbin J, et al: Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation 1991;83:1592-1597.
20. Epstein ND, Fananapazir L, Lin HJ, et al: Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 1992;85:635-647.
21. Watkins H, MacRae C, Thierfelder L, et al: A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nature (Genetics) 1993;3:333-337.
22. Thierfelder LC, MacRae C, Watkins II, et al: A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90:6270-6274.
23. Carrier L, Hengstenberg C, Beckmann JS, et al: Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature (Genetics) 1993;4:311-313.
24. MacRae CA, Ghaisas N, Kass S, et al: Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995;96:1216-1220.
25. Liew CC, Sole MJ, Yamauchi-Takihara K, et al: Complete sequence and organization of the human cardiac ß-myosin heavy chain gene. Nucleic Acids Res 1990; 18:3647-3651.
26. Swynghedauw B: Development and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986;66:710-771.
27. Finer JT, Simmons RM, Spudich JA: Single myosin mechanics: PicoNewton forces and nanometer steps. Nature 1994;368:113-119.
28. Ishijima A, Harada Y, Kojima H, et al: Single-molecule analysis of the acto-myosin motor using nano-manipulation. Biochem Biophys Res Commun 1994;199: 1057-1063.
29. Watkins H, Thierfelder L, Anan R, et al: Independent origin of identical β cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 1993;53:1180-1185.
30. Dausse E, Komajda M, Fetler L, et al: Familial hypertrophic cardiomyopathy: Microsatellite haplotyping and identification of a hot spot for mutations in the β-myosin heavy chain gene. J Clin Invest 1993;92:2807-2813.
31. 719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Human Mol Genet 1994;3: 1025-1026.
32. Marian AJ, Yu QT, Mares A Jr., et al: Detection of a new mutation in the beta myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest 1992;90:2156-2165.
33. Watkins H, Thierfelder L, Hwang DS, et al: Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992;90:1666-1671.
34. Greve G, Bachinski LL, Friedman DL, et al: Isolation of a de novo mutant myocardial βMHC protein in a pedigree with hypertrophic cardiomyopathy. Human Mol Genet 1994;3:2073-2075.
35. Mesnard L, Samson F, Espinasse I, et al: Molecular cloning and developmental expression of human cardiac troponin T. FEBS Lett 1993;328:139-144.
36. Townsend PJ, Farza H, MacGeon C, et al: Human cardiac troponin T: Identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics 1994;21:311-316.
37. Mesnard L, Logeart D, Taviaux S, et al: Human cardiac troponin T: Cloning and expression of new isoforms in the normal and failing heart. Circ Res 1995; 76:687-692.
38. Anderson PAW, Greig A, Mark TM, et al: Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 1995;76:681-686.
39. Farah CS, Reinach FC: The troponin complex and regulation of muscle contraction. FASEB J 1995;9:755-767.
40. Watkins H, McKenna WJ, Thierfelder L, et al: Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.
41. Forissier J-F, Carrier L, Farza H, et al: Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996;94:3096-3073.
42. Zot AS, Potter JD: Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Chem 1987;16:535-559.
43. Watkins H, Anan R, Coviello DA, et al: A de novo mutation in a tropomyosin that causes hypertrophic cardiomyopathy. Circulation 1995;91:2302-2305.
44. Freiburg A, Gautel M: A molecular map of the interactions between titin and myosin-binding protein C: Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 1996;235: 317-323.
45. Kellermayer MSZ, Smith SB, Granzier HL, et al: Folding-unfolding transitions in single titin molecules characterized with laser tweezers. Science 1997;276:1112-1116.
46. Carrier L, Bonne G, Bahrend E, et al: Organization and sequence of human cardiac myosin binding protein C gene (MyBPCS) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997;80:427-434.
47. Gautel M, Zuffardi O, Freiburg A, et al: Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? EMBO J 1995;14:1952-1960.
48. Rottbauer W, Gautel M, Zehelein J, et al: Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest 1997;100:475-482.
49. Lowey S, Waller GS, Trybus KM: Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 1993;365:454-456.
50. Morano M, Zacharzowski U, Maier M, et al: Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest 1996;98:467-473.
51. Gulick J, Hewettt TE, Klevitsky R, et al: Transgenic remodeling of the regulatory light chains in the mammalian heart. Circ Res 1997;80:655-664.
52. Sweeney HL, Bowmann BF, Stull JT: Myosin light chain phosphorylation in vertebrate striated muscle: Regulation and function. Am J Physiol 1993;264: C1085-C1095.
53. Tohtong R, Yamashita H, Graham M, et al: Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature 1995;374:650-653.
54. Bermingham N. Mapping TNNCI, the gene that encodes cardiac troponin I in the human and mouse. Genomics 1995;30:620-622.
55. Maron BJ, Lipson LC, Roberts WC, et al: "Malignant" hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 1978;41:1133-1140.
56. Abchee A, Marian AJ: Prognostic significance of β-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Invest Med 1997;45:191-196.
57. Marian AJ, Yu Q-T, Workman R, et al: Angiotensin converting enzyme polymorphism is associated with hypertrophic cardiomyopathy as well as sudden cardiac death. Lancet 1993;342:1073-1074.
58. Lechin M, Quinones M, Omran A, et al: Angiotensin 1 converting enzyme genotypes influence the phenotypic expression of hypertrophic cardiomyopathy. Circulation 1995;92:1808-1812.
59. Geisterfer-Lowrance AAT, Christe M, Conner DA, et al: A mouse model for familial hypertrophic cardiomyopathy. Science 1996;272:731-734.
60. Watkins H, Rosenweig A, Hwang D, et al: Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-1114..
61. Anan R, Greve G, Thierfelder L, et al: Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-285.
62. Marian AJ, Mares A, Kelley D, et al: Sudden death in hypertrophic cardiomyopathy: Genotype-phenotype correlation of beta myosin heavy chain mutations. Eur Heart J 1995;16:368-376.
63. 403Arg-Gln mutation. Circulation 1992;86:345-352.
64. Fananapazir L, Epstein ND: Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 1994;89:22-32.
65. Marian AJ: Sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside with an emphasis on genetic markers. Clin Cardiol 1994;18: 189-198.
66. Moolman J, Corfield VA, Rosen B, et al: Sudden death due to troponin T mutations. J Am Coll Cardiol 1997; 29:549-555.
67. Coviello DA, Maron BJ, Spirito P, et al: Clinical feature of hypertrophic cardiomyopathy caused by mutations of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol 1997;29:635-640.
68. Cuda G, Fananapazir L, Zhu W, et al: Skeletal muscle expression and abnormal function of beta myosin in hypertrophic cardiomyopathy. J Clin Invest 1993;91: 2861-2865.
69. Sweeney HL, Straceski AJ, Leinwand LA, et al: Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994; 269:1603-1605.
70. Lankford EB, Epstein ND, Fananapazir L, et al: Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995; 95:1409-1414.
71. Straceski AJ, Geisterfer-Lowrance A, Seidman CE, et al: Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 1994;91:589-593.
72. Marian AJ, Yu Q-T, Mann D, et al: Expression of the mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res 1995;77:98-106.
73. Berul CL, Christe ME, Aronovitz MJ, et al: Electrophysiological abnormalities and arrhythmias in αMHC mutant familial hypertrophic cardiomyopathy in mice. J Clin Invest 1997;99:570-576.
74. Vikstrom KL, Factor SM, Leinwand LA: Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 1996; 2:556-567.
75. Lin D, Bobkova A, Homsher E, et al: Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 1996;97:2842-2848.
76. Watkins H, Seidman CE, Seidman JG, et al: Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest 1996;98:2456-2461.
77. 92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocytes contractility. Circ Res 1997;81;76-85.
78. Golistina N, An Y, Greenfield NJ, et al: Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function. Biochemistry 1997;36:4637-4642.
79. Hengstenberg C, Maisch B: Increased nuclear protooncogene expression in hypertrophic cardiomyopathy. Cardioscience 1993;1:15-20.
80. Derchi G, Bellone P, Chiarella F, et al: Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol 1992;70:1502-1504.
81. Hasegawa K, Fujiwara H, Doyama K, et al: Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372-380.
82. Li R-K, Li G, Mickle DAG, et al: Overexpression of transforming growth factor-β1 and insulin-like growth factor-1 in patients with idiopathic hypertrophic cardiomyopathy. Circulation 1997;96:874-881.
83. Jones WK, Grupp IL, Doetschman T, et al: Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 1996;98:1906-1917.